Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
166.3 USD | -0.83% | +4.83% | -7.67% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.67% | 9.37B | |
-4.92% | 185B | |
-0.86% | 109B | |
-3.95% | 68.54B | |
+2.70% | 51.74B | |
+8.98% | 45.22B | |
+3.12% | 41.74B | |
+3.94% | 26.83B | |
+3.00% | 26.69B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $155.7M, vs. Street Est of $156.3M